Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2017-05-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (瑞华会计师事务所) as the company's auditor for the 2017 fiscal year. It details the board's approval, audit fees, and independent directors' opinions on the auditor's qualifications. There is no actual audit report or financial statements included, only a notice about the auditor appointment and the need for shareholder approval at the upcoming annual general meeting. The document length is short (636 characters), and it serves as a formal announcement rather than the audit report itself. Therefore, it fits best under 'Audit Report / Information' (AR) as it relates to audit matters but is not a full annual report or audit report document itself. However, since it is an announcement about auditor appointment and not the audit report or results, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for such announcements that do not fit other categories.
2017-05-02 Chinese
关于召开终止重大资产重组投资者说明会的预告公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the scheduling of an investor explanation meeting about the termination of a major asset restructuring. It includes details about the meeting time, location, participants, and how investors can participate. The document does not contain financial statements or detailed financial data, nor is it a transcript of the meeting itself. It is essentially a notice or announcement about an upcoming event related to corporate actions. Therefore, it fits best into the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit into more specific categories like M&A Activity or Management Reports.
2017-05-02 Chinese
东兴证券股份有限公司关于公司终止发行股份及支付现金购买资产并募集配套资金暨关联交易之独立财务顾问核查意见
Regulatory Filings
2017-05-02 Chinese
第八届董事会第七十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. regarding the resolution passed at the 71st meeting of the 8th board. The key content is the approval to terminate a major asset restructuring plan. It details the background of the proposed major asset restructuring, the involved parties, the reasons for termination, and the voting results. The document is an official announcement of a board decision related to a major corporate event (termination of a major asset restructuring). It is not a full annual or interim report, audit report, or earnings release. It is not a proxy statement or voting result announcement from a shareholder meeting, but a board meeting resolution announcement. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (1307 characters), and it contains substantive content about the board resolution, not just a notice or report publication announcement. Therefore, the classification is MANG with high confidence.
2017-05-02 Chinese
关于终止本次重大资产重组事项的说明
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from a company regarding the termination of a major asset restructuring (重大资产重组) process. It details the reasons for termination, the process, legal compliance, and the impact on the company. It also mentions a scheduled investor meeting to explain the termination and plans for stock resumption. The document is short (1543 characters) and serves as an official notice about the cessation of a capital restructuring event rather than the restructuring report itself. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2017-05-02 Chinese
独立董事关于第八届董事会第七十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the 2016 annual profit distribution plan and the reappointment of the auditing firm for 2017. It references compliance with governance codes and company articles, and it is related to board meeting matters. The document does not contain full financial statements or detailed audit results but provides an opinion on governance and audit firm reappointment. This fits best under Board/Management Information (MANG) as it concerns board meeting decisions and independent directors' opinions on governance matters, rather than a full audit report or annual report. The document length is short and focused on governance opinions rather than financial data or audit results.
2017-04-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.